Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms MIDAS
- Sponsors Martek Biosciences Corporation
- 04 Nov 2010 Results from this trial were published in the November issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association, according to a Martek Biosciences media release.